The so-called “prophylactic” drugs do not cure migraines, but they are intended to reduce the intensity and frequency of attacks. They are a primary treatment and should generally be taken every day. The preventive effect may take 2 to 3 months to appear.
BiofluActiFast happens to be one mild analgesic as well as antipyretic. It is optional for pain treatment or febrile conditions. The bioflu uses include headaches, tension headaches or migraine, backache, toothache, muscle, rheumatic pains, sore throat, dysmenorrhea, and dismissing the aches, fever, and pains from colds and flu. The Bioflu Infant 120 mg/5 ml Colour Free Sugar-Free Oral Suspension is used for the treatment of mild pain.
The Use of the Drugs
These drugs are usually only prescribed for people who have frequent migraines (3 or more attacks per month) and whose activities are disturbed enough to warrant medication. But there is not really an established rule: the initiation of treatment is discussed on a case-by-case basis with the doctor. Be aware that some drugs have side effects, and their long-term effectiveness is not guaranteed. However, for people with severe and frequent migraines, prophylactic medications can be a blessing.
Treatments of Migraine
Although migraine is a significant public health problem, since it affects 11% of the population, patients often remain dissatisfied with their treatment. The diagnosis of migraines is made clinically, in front of typically unilateral, pulsatile headaches, accompanied by nausea or photo- and phonophobia, and which can sometimes be preceded by an aura. There are, however, certain red flags that should lead to the performance of brain imaging. Therapeutic management is based on avoiding triggering factors, on the treatment of seizures using simple analgesics or triptans, and, under certain conditions, on background treatment with antihypertensives, antiepileptics, or antidepressants, with as the keystone of care, the good doctor-patient relationship.
Migraines are a significant public health problem. According to the WHO, 46% of the population suffer from operational headaches and 11% from migraines, which places headaches in the tenth place in the world among the most disabling pathologies of all sexes combined. In fifth place for women. 1 Direct and indirect expenses linked to absenteeism for migraine represented a public health cost of more than 40 billion euros at the European level in 2010.
Despite a significant functional impact in the professional, domestic and relational fields, many patients never seek medical help for their migraines. The majority of patients who do so remain dissatisfied with their care.
Clinical Presentation
A migraine attack evolves in several phases. First of all, prodromes such as irritability, sensitivity to light, or fatigue, lasting from a few hours to a few days, can precede the headache. The latter last from 4 to 72 hours (in the absence of treatment) and can be followed by postdrome for 24 to 48 hours, during which the patient describes, for example, difficulty concentrating and fatigue. During a migraine attack, the patient will often be forced to stop current activities, especially physical ones, and will seek to isolate themselves in peace and the dark.
For 20% of migraine sufferers, an aura may be present between the prodromes and headaches. This is a 5- to 60-minute episode of completely reversible, gradually onset neurological symptoms. These symptoms are most frequently visual (scintillating scotoma, hemianopia, etc.) but can also affect language (aphasia), motor skills (hemiparesis), or sensitivity. With Bioflu, the options are all there now.
Comments are closed.